Free Trial

Horizon Kinetics Medical ETF Rating

$29.31
+0.04 (+0.14%)
(As of 11/4/2024 ET)

Horizon Kinetics Medical ETF Aggregate Rating and Price Target (2024)

MarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.

MEDX Aggregate Rating

Moderate Buy
2.68

Holdings in MEDX have an aggregate rating of Moderate Buy based on 392 analyst ratings issued in the past year covering 31 companies (87.5% of the portfolio).

MEDX Aggregate Price Target

$39.50
34.75% Upside
High Prediction$51.20
Average Prediction$39.50
Low Prediction$27.79

Holdings in MEDX have an aggregate price target of $39.50 and a range of $27.79 to $51.20 covering 31 companies (87.5% of the portfolio).

MEDX Consensus Ratings of Holdings

Strong Buy
0 Strong Buy rating(s)
Buy
5 Buy rating(s)
Moderate Buy
21 Moderate Buy rating(s)
Hold
4 Hold rating(s)
Reduce
1 Reduce rating(s)
Sell
0 Sell rating(s)
Strong Sell
0 Strong Sell rating(s)

Ratings for Stocks Held by Horizon Kinetics Medical ETF

 
 
Strong Sell
Sell
Reduce
Hold
Moderate Buy
Buy
Strong Buy

Ratings for the Top 31 MEDX Holdings

Weight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)View
Ratings
16.03%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$806.14
-1.6%
4.9808 of 5 stars
2.84$1,008.41 25.1%19Earnings Report
Dividend Announcement
Analyst Forecast
Analyst Revision
9.00%
AbbVie Inc. stock logo
ABBV
AbbVie
$200.47
-1.5%
4.8436 of 5 stars
2.84$201.00 0.3%20Earnings Report
Dividend Increase
Analyst Upgrade
Analyst Revision
6.18%
Amgen Inc. stock logo
AMGN
Amgen
$316.91
-0.7%
4.5092 of 5 stars
2.50$333.50 5.2%24Earnings Report
Analyst Upgrade
Analyst Revision
5.69%
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
$55.45
+2.1%
4.5228 of 5 stars
1.93$53.00 -4.4%14Earnings Report
Analyst Forecast
Analyst Revision
5.10%
AstraZeneca PLC stock logo
AZN
AstraZeneca
$71.43
+0.0%
4.3913 of 5 stars
2.91$89.75 25.6%11Options Volume
4.69%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$158.24
-1.2%
4.9751 of 5 stars
2.54$175.93 11.2%13
4.41%
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
$269.95
-1.4%
3.806 of 5 stars
2.75$294.50 9.1%24Earnings Report
Analyst Forecast
4.22%
Pfizer Inc. stock logo
PFE
Pfizer
$27.76
-1.2%
4.9858 of 5 stars
2.60$33.58 21.0%15Earnings Report
Analyst Revision
3.95%
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$101.87
0.0%
4.9986 of 5 stars
2.88$129.93 27.5%17Earnings Report
Analyst Forecast
3.47%
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$828.84
-1.7%
4.8372 of 5 stars
2.71$1,097.25 32.4%21Analyst Forecast
3.40%
Alkermes plc stock logo
ALKS
Alkermes
$26.59
+0.5%
4.8919 of 5 stars
2.50$34.90 31.3%10
3.12%
Biogen Inc. stock logo
BIIB
Biogen
$173.52
-0.2%
4.8315 of 5 stars
2.62$261.58 50.8%26Earnings Report
Analyst Forecast
Analyst Revision
High Trading Volume
2.82%
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
$50.59
-0.3%
2.9747 of 5 stars
2.37$75.19 48.6%19
2.75%
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
$38.44
-0.8%
4.2378 of 5 stars
2.68$61.00 58.7%19Upcoming Earnings
Analyst Upgrade
2.38%
GSK plc stock logo
GSK
GSK
$36.97
+0.2%
4.3771 of 5 stars
2.78$50.00 35.2%9Dividend Increase
1.94%
Bicycle Therapeutics plc stock logo
BCYC
Bicycle Therapeutics
$23.46
+3.3%
2.7396 of 5 stars
2.88$45.13 92.3%8Earnings Report
Upcoming Earnings
Analyst Forecast
Gap Down
1.21%
Beam Therapeutics Inc. stock logo
BEAM
Beam Therapeutics
$24.36
+6.2%
3.1394 of 5 stars
2.60$45.80 88.0%10Upcoming Earnings
1.18%
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
$15.14
+2.2%
4.2719 of 5 stars
2.76$59.13 290.6%17
0.97%
Replimune Group, Inc. stock logo
REPL
Replimune Group
$12.02
+1.0%
3.6719 of 5 stars
3.17$16.80 39.8%6Upcoming Earnings
0.78%
Haleon plc stock logo
HLN
Haleon
$9.76
+0.3%
3.6256 of 5 stars
3.00$10.95 12.2%6News Coverage
0.76%
Galectin Therapeutics Inc. stock logo
GALT
Galectin Therapeutics
$2.53
+0.8%
1.4918 of 5 stars
3.00$11.00 335.6%1Upcoming Earnings
Positive News
0.69%
Vanda Pharmaceuticals Inc. stock logo
VNDA
Vanda Pharmaceuticals
$4.85
+4.1%
3.9522 of 5 stars
3.00$15.50 219.6%2Upcoming Earnings
Analyst Forecast
Analyst Revision
0.53%
Editas Medicine, Inc. stock logo
EDIT
Editas Medicine
$2.88
-1.0%
4.6623 of 5 stars
2.42$9.91 244.1%12Analyst Downgrade
High Trading Volume
0.52%
Lantern Pharma Inc. stock logo
LTRN
Lantern Pharma
$3.28
-0.9%
1.0523 of 5 stars
2.001Upcoming Earnings
Gap Down
0.48%
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
$86.99
+0.0%
4.0353 of 5 stars
2.60$94.36 8.5%15Earnings Report
0.43%
2seventy bio, Inc. stock logo
TSVT
2seventy bio
$4.51
+2.5%
1.7399 of 5 stars
2.56$9.00 99.6%9
0.28%
Allogene Therapeutics, Inc. stock logo
ALLO
Allogene Therapeutics
$3.00
+10.3%
3.1007 of 5 stars
2.73$9.96 231.9%11Upcoming Earnings
0.24%
Viatris Inc. stock logo
VTRS
Viatris
$11.45
-1.5%
2.532 of 5 stars
2.50$14.00 22.3%2Upcoming Earnings
0.14%
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
$2.51
+2.9%
2.8517 of 5 stars
2.53$4.50 79.3%15Upcoming Earnings
0.10%
bluebird bio, Inc. stock logo
BLUE
bluebird bio
$0.46
3.0077 of 5 stars
2.25$4.63 900.7%12Upcoming Earnings
Analyst Forecast
0.05%
Mural Oncology plc stock logo
MURA
Mural Oncology
$3.40
-1.7%
3.6535 of 5 stars
3.25$16.00 370.6%4

This page (NASDAQ:MEDX) was last updated on 11/4/2024 by MarketBeat.com Staff
From Our Partners